On August 10^th 2017, the Therapeutic Goods Administration (TGA) held a workshop titled Regulatory considerations for additive manufacturing (3D printing) in the medical field.

3D printing is already used in large volume production of devices to a standard design as an alternative to traditional subtractive manufacturing, but this technology is becoming increasingly popular in medicine as a way to overcome patient-specific challenges, in particular in the area of cranial and facial reconstruction and orthopaedic implants.